Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
the COVID-19 drug remdesivir. Gilead is now going on the offensive in Europe. The European Patent Office recently granted EP 3 854 403. The patent belongs to the Academy of Military Medical Sciences
Medical Sciences of China. This ruling renders the pharmaceutical use patent for remdesivir in the treatment of COVID-19 infections invalid in all UPC contracting states. According to information, the
in line for a Chinese patent for its drug called Remdesivir, which shows promise against the broad family of coronaviruses. But now a team of Chinese scientists say they’ve improved and targeted its
total 1 pages, 3 items
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
